AAAAAA
Results: 1-25/36
Authors:
CHARLON V
KOBRIN I
Citation: V. Charlon et I. Kobrin, THE EFFICACY AND SAFETY OF MIBEFRADIL IN SUBGROUPS OF PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS, International journal of clinical practice, 52(4), 1998, pp. 257-264
Authors:
TZIVONI D
GILULA Z
KLUTSTEIN M
REISIN L
BOTVIN S
KOBRIN I
Citation: D. Tzivoni et al., EFFECT OF MIBEFRADIL (MIB) ON DAILY ISCHEMIC EPISODES WITH AND WITHOUT INCREASE IN HEART-RATE, Journal of the American College of Cardiology, 31(2), 1998, pp. 447-447
Authors:
WOITTIEZ AJJ
HUYSMANS FTM
BAILEY R
ROBSON RA
MION D
VILLA G
KOBRIN I
Citation: Ajj. Woittiez et al., A COMPARISON OF THE SAFETY AND EFFICACY OF MIBEFRADIL AND NIFEDIPINE SR IN PATIENTS WITH RENAL-DISEASE AND HYPERTENSION, Clinical nephrology, 49(3), 1998, pp. 160-166
Authors:
KOBRIN I
PORDY R
Citation: I. Kobrin et R. Pordy, GENDER DIFFERENCES IN RESPONSE TO TREATMENT WITH MIBEFRADIL, A SELECTIVE T-CHANNEL BLOCKER, Journal of hypertension, 16, 1998, pp. 27106-27106
Authors:
KOBRIN I
BIESKA G
CHARLON V
LINDBERG E
PORDY R
Citation: I. Kobrin et al., ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, A NEW T-TYPE CALCIUM-CHANNEL ANTAGONIST, Cardiology, 89, 1998, pp. 23-32
Authors:
SCHNEEWEISS A
KOBRIN I
CHARLON V
CASPI A
MARMOR A
SCLAROVSKY S
REISIN L
SCHLESINGER Z
Citation: A. Schneeweiss et al., ADDING THE NEW CALCIUM-ANTAGONIST MIBEFRADIL TO PATIENTS RECEIVING LONG-TERM BETA-BLOCKER THERAPY RESULTS IN IMPROVED ANTIANGINAL AND ANTIISCHEMIC EFFICACY, The American heart journal, 135(2), 1998, pp. 272-280
Authors:
CARNEY S
WING L
RIBEIRO A
KALLWELLIS R
ZIMLICHMAN R
VISKOPER RJ
MION D
KOBRIN I
Citation: S. Carney et al., THE ADDITION OF MIBEFRADIL TO CHRONIC HYDROCHLOROTHIAZIDE THERAPY IN HYPERTENSIVE PATIENTS IS ASSOCIATED WITH A SIGNIFICANT ANTIHYPERTENSIVE EFFECT, Journal of human hypertension, 11(7), 1997, pp. 459-466
Authors:
VISKOPER RJ
BERNINK PJLM
SCHELLING A
RIBEIRO AB
KANTOLA IM
WILKINS MR
KOBRIN I
Citation: Rj. Viskoper et al., A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING MIBEFRADIL AND AMLODIPINE - 2 LONG-ACTING CALCIUM-ANTAGONISTS WITH SIMILAR EFFICACY BUT DIFFERENT TOLERABILITY PROFILES, Journal of human hypertension, 11(6), 1997, pp. 387-393
Authors:
OPARIL S
KOBRIN I
ABERNETHY DR
LEVINE BS
REIF MC
SHEPHERD AM
Citation: S. Oparil et al., DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION, American journal of hypertension, 10(7), 1997, pp. 735-742
Authors:
KOBRIN I
Citation: I. Kobrin, DIFFERENTIAL PROPERTIES OF MIBEFRADIL IN HYPERTENSION AND ANGINA, Journal of hypertension, 15, 1997, pp. 33-40
Authors:
BUHLER FR
COHN JN
HERMSMEYER K
MENARD J
ABERNETHY DR
KOBRIN I
PRATT CM
Citation: Fr. Buhler et al., NEW STRATEGIES IN CARDIOVASCULAR-DISEASE MANAGEMENT - SUMMARY OF ROUND-TABLE DISCUSSION, Journal of hypertension, 15, 1997, pp. 1-3
Authors:
KOBRIN I
CHARLON V
Citation: I. Kobrin et V. Charlon, PREDICTABLE CLINICAL EFFECTS IN THE TREATMENT OF HYPERTENSION AND CHRONIC, STABLE ANGINA-PECTORIS - CLINICAL-STUDIES OF MIBEFRADIL, Journal of hypertension, 15, 1997, pp. 35-40
Authors:
MASSIE BM
CHRYSANT SG
JAIN A
WEIR M
WEISS R
KOBRIN I
Citation: Bm. Massie et al., ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL - A DOUBLE-BLIND COMPARISON WITH DILTIAZEM-CD, Clinical cardiology, 20(6), 1997, pp. 562-568
Authors:
ROSENQUIST M
BREMBILLAPERROT B
MEINERTZ T
NEUGEBAUER A
CRIJNS HJMG
SMEETS JLRM
VANDERVRING JAFM
FROMER M
KOBRIN I
Citation: M. Rosenquist et al., THE ACUTE EFFECTS OF INTRAVENOUSLY ADMINISTERED MIBEFRADIL, A NEW CALCIUM-ANTAGONIST, ON THE ELECTROPHYSIOLOGIC CHARACTERISTICS OF THE HUMAN HEART, European Journal of Clinical Pharmacology, 52(1), 1997, pp. 7-12
Authors:
KOBRIN I
CHARLON V
LINDBERG E
NEUMANN N
PORDY R
Citation: I. Kobrin et al., MIBEFRADIL - A NEW T-CHANNEL SELECTIVE CALCIUM-ANTAGONIST, Medicamentos de actualidad, 33(8), 1997, pp. 523-542
Authors:
KOBRIN I
CHARLON V
BURSZTYN M
Citation: I. Kobrin et al., NEW DEVELOPMENTS IN DRUG-THERAPY OF HYPERTENSION, The Medical clinics of North America, 81(6), 1997, pp. 1359
Authors:
ALPERT JS
BAKX A
SCHNEEWEISS A
CASPI A
CHARLON V
KOBRIN I
Citation: Js. Alpert et al., TREATMENT OF CHRONIC STABLE ANGINA-PECTORIS WITH COMBINATION MIBEFRADIL AND BETA-BLOCKER THERAPY, Circulation, 96(8), 1997, pp. 2607-2607
Authors:
TZIVONI D
KADR H
BRAAT S
RUTSCH W
RAMIRES JA
KOBRIN I
Citation: D. Tzivoni et al., EFFICACY OF MIBEFRADIL COMPARED WITH AMLODIPINE IN SUPPRESSING EXERCISE-INDUCED AND DAILY SILENT ISCHEMIA - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED TRIAL, Circulation, 96(8), 1997, pp. 2557-2564
Authors:
OPARIL S
BERNINK P
BURSZTYN M
CARNEY S
KOBRIN I
Citation: S. Oparil et al., ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL IN THE TREATMENT OF MILD-TO-MODERATE SYSTEMIC HYPERTENSION, The American journal of cardiology, 80(4B), 1997, pp. 12-19
Authors:
ALPERT JS
BAKX ALM
BRAUN S
FRISHMAN WH
SCHNEEWEISS A
TZIVONI D
KOBRIN I
Citation: Js. Alpert et al., ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL IN THE TREATMENT OF PATIENTS WITH CHRONIC STABLE ANGINAL PECTORIS, The American journal of cardiology, 80(4B), 1997, pp. 20-26
Authors:
MASSIE BM
LACOURCIERE Y
VISKOPER R
WOITTIEZ A
KOBRIN I
Citation: Bm. Massie et al., MIBEFRADIL IN THE TREATMENT OF SYSTEMIC HYPERTENSION - COMPARATIVE-STUDIES WITH OTHER CALCIUM-ANTAGONISTS, The American journal of cardiology, 80(4B), 1997, pp. 27-33
Authors:
DAVIES GJ
TZIVONI D
KOBRIN I
Citation: Gj. Davies et al., MIBEFRADIL IN THE TREATMENT OF CHRONIC STABLE ANGINA-PECTORIS - COMPARATIVE-STUDIES WITH OTHER CALCIUM-ANTAGONISTS, The American journal of cardiology, 80(4B), 1997, pp. 34-39
Authors:
KOBRIN I
CHARLON V
LINDBERG E
PORDY R
Citation: I. Kobrin et al., SAFETY OF MIBEFRADIL, A NEW ONCE-A-DAY, SELECTIVE T-TYPE CALCIUM-CHANNEL ANTAGONIST, The American journal of cardiology, 80(4B), 1997, pp. 40-46
Authors:
ALPERT JS
KOBRIN I
DEQUATTRO V
FRIEDMAN R
SHEPHERD A
FENSTER PE
THADANI U
Citation: Js. Alpert et al., ADDITIONAL ANTIANGINAL AND ANTIISCHEMIC EFFICACY OF MIBEFRADIL IN PATIENTS PRETREATED WITH A BETA-BLOCKER FOR CHRONIC STABLE ANGINA-PECTORIS, The American journal of cardiology, 79(8), 1997, pp. 1025-1030
Authors:
DAVIES GJ
KOBRIN I
CASPI A
REISIN LH
DEALBUQUERQUE DC
ARMAGNIJAN D
COELHO OR
SCHNEEWEISS A
Citation: Gj. Davies et al., LONG-TERM ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, THE NEVER T-TYPE CALCIUM-CHANNEL BLOCKER - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED COMPARISON WITH SUSTAINED-RELEASE DILTIAZEM, The American heart journal, 134(2), 1997, pp. 220-228